Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Amerigen Pharmaceuticals Inc.

Amerigen Pharmaceuticals Inc. Recalls

All product recalls associated with Amerigen Pharmaceuticals Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Feb 2019

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–4 of 4 recalls

Temozolomide Capsules (Amerigen) – Failed Dissolution (2019)

Failed dissolution specifications

Class IIILow

FDAFeb 19, 2019Nationwide• Amerigen Pharmaceuticals Inc.

Temozolomide Capsules (Amerigen) – Failed Dissolution (2018)

Failed Dissolution Specifications

Class IIILow

FDADec 20, 2018Nationwide• Amerigen Pharmaceuticals Inc.

Temozolomide Capsules (Amerigen) – Failed Dissolution (2018)

Failed Dissolution Specifications

Class IIILow

FDA

Dec 20, 2018

Nationwide

• Amerigen Pharmaceuticals Inc.

Temozolomide Capsules (Amerigen) – Dissolution Specification Failure (2018)

Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.

Class IIILow

FDAOct 5, 2018Nationwide• Amerigen Pharmaceuticals Inc.